Site Search
Search Results
The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and Survivorship
... screening services alone have averted approximately 4.75 million deaths from breast, cervical, colorectal, lung and prostate cancers. Millions of people risk losing access to preventive services if cost sharing is required. Thanks to current protections in law, a vast majority of Americans have access to preventive services without cost ... negatively impact access to cancer prevention and screening, especially for the millions of people with limited incomes, for whom these payments can represent a significant percentage of their income. The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and ...
Survivor Views: Preventive Care Coverage, Medical Debt, & Food Insecurity
Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... v. Becerra case which could challenge the ACA requirement that most private insurance plans cover recommended preventive care services without cost sharing. Finding ways to help cancer patients stay out of medical debt and reduce the negative impacts of medical debt they have already ...
Factors Influencing Cancer Disparities
The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through ... with cancer. Clinical trials are also a key part of research and enable the development of better drugs and treatments for cancer. However, cost is often a barrier to enrollment because trial participants are frequently responsible for non-medical costs such as transportation and ...